VacciXcell was established by the 2nd generation founders of the ESCO group of companies, a world leader in laboratory, medical and pharmaceutical equipment solutions since 1978. Following the same guiding principles of the ESCO founders, VacciXcell founders believe in being part of the solution and aim to solve the challenges in manufacturing large volumes of vaccines, cell and regenerative therapeutics and biosimilars in a cost effective manner.
VacciXcell envisions a world where all nations are self-sufficient in the manufacture and administration of vaccines and have access to high quality biosimilars. VacciXcell further envisions a world where cell and regenerative therapies are readily available.
With its Global HQ in Singapore and worldwide presence, VacciXcell has the resources, in-house technologies, expertise, dedication and distribution channels to make this vision a success.
VacciXcell offers a wide range of products and services for end-to-end vaccine, cell and regenerative therapies, and biosimilars technology solutions, starting from production, QC/IPQC, warehousing and cold chain, logistics and inventory control to administration.